查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2065207

遠端患者監護設備市場預測至2034年－按產品類型、設備配置、技術、分銷管道、應用、最終用戶和地區分類的全球分析

Remote Patient Monitoring Devices Market Forecasts to 2034 - Global Analysis By Product Type (Vital Sign Monitors and Specialized Monitors), Device Form, Technology, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球遠端患者監護設備市場預計將在 2026 年達到 61 億美元，到 2034 年達到 194 億美元，預測期內複合年成長率為 15.6%。

遠端患者監護(RPM) 設備涵蓋了廣泛的醫療硬體和連網數位工具，旨在傳統臨床環境之外收集、傳輸和分析患者的生理數據。這些設備包括生命徵象監視器、穿戴式生物感測器、植入式心臟設備和多參數平台，能夠為慢性病患者或術後復健患者提供持續的健康監測。 RPM 設備透過即時連接患者和醫療團隊，有助於減少再入院率、支持預防性臨床干預、降低醫療成本，並幫助患者積極主動管理自身健康。

慢性病盛行率上升和全球老化問題日益嚴重。

全球慢性疾病負擔日益加重，例如心血管疾病、糖尿病、高血壓和呼吸系統疾病，這推動了對持續監測技術的持續需求，以便在兩次就診之間進行主動式健康管理。全球老化進一步加劇了這一需求，因為老年人需要頻繁的健康評估，而傳統的面對面模式無法有效滿足這一需求。遠距患者監護 (RPM) 設備可為臨床醫生提供長期健康數據流，從而實現及時干預，減緩疾病進展並減少昂貴的急診住院治療。在主要市場擴大遠端監測項目的保險覆蓋範圍，正在促進醫療服務提供者和患者的接受度。

地方資料隱私法規和通訊基礎設施限制

使用遠距患者監護 (RPM) 設備收集和傳輸高度敏感的患者健康數據，對醫療服務提供者和設備製造商提出了嚴格的合規要求，這些要求受到 HIPAA、GDPR 以及新興的國家數位健康法規等框架的限制。確保端到端資料加密、病患知情同意管理和稽核追蹤的完整性，增加了營運的複雜性和成本。此外，農村和偏遠地區不穩定的寬頻和行動電話連接阻礙了 RPM 有效性所依賴的即時數據傳輸。這種基礎設施的匱乏造成了 RPM 服務取得方面的地域不平等，限制了 RPM 在最需要臨床效益的社區的市場滲透率。

人工智慧分析的整合和居家醫療模式的擴展

遠端患者監測（RPM）硬體與人工智慧分析平台的整合，可將原始生理數據轉化為可操作的臨床洞察，從而實現對病情惡化的預測性預警和個人化治療方案提案。這項高價值功能正吸引眾多醫療系統、保險公司和科技公司的龐大投資，他們都希望藉此提升遠距醫療服務的差異化優勢。同時，受成本壓力、患者偏好以及疫情後醫療模式轉型等因素的驅動，醫療服務結構正朝著居家醫療轉變，這推動了RPM設備在慢性病管理、術後監測和老年護理等領域的市場擴張。

對設備準確性的擔憂以及報銷政策的不確定性。

許多進入臨床監測領域的消費級穿戴裝置缺乏嚴格的醫學檢驗，這引發了人們對其準確性和合規性的嚴重擔憂。臨床醫生對依賴那些在不同患者群體（例如膚色較深或BMI較高的人群）中性能存在差異的設備數據仍然持謹慎態度。此外，不同保險公司和地區對遠端患者監測（RPM）服務的報銷政策仍然存在差異，這給投資監測基礎設施的醫療機構帶來了不確定性。遠端醫療計費代碼的修訂和更嚴格的申請標準可能會對RPM計畫的採用率和投資回收期產生重大影響。

新型冠狀病毒（COVID-19）的影響：

新冠疫情大大加速了責任病患管理（RPM）的普及，因為醫療系統緊急將非緊急病患監測轉移出醫院，以確保醫院床位能夠用於救治新冠重症病患。緊急放寬管制措施使得RPM得以快速部署，並擴大了遠端醫療的報銷範圍，從而建立了新的醫療服務模式，這些模式在疫情危機後依然有效。疫情凸顯了RPM即使在醫療系統中斷的情況下也能維持醫療服務的連續性，促使醫療系統和政策制定者將RPM正式納入標準診療流程，並投資建設可擴展的數位醫療基礎設施，以增強未來的應對能力。

在預測期內，生命徵象監測領域預計將佔據最大的市場佔有率。

預計在整個預測期內，生命徵象監測領域將佔據最大的市場佔有率，其中包括血壓計、脈動式血氧監測儀系統和心電圖/心率監測儀等高需求設備。這些基礎監測工具能夠滿足慢性病管理中最廣泛的需求，並被廣泛應用於「居家照護」計畫、出院後照護和長期疾病管理。持續的產品創新，例如在緊湊且易於使用的外形尺寸中提供臨床級別的精度，預計將使該領域在整個預測期內保持主導的銷售貢獻。

預計在預測期內，人工智慧監控平台細分市場將呈現最高的複合年成長率。

在預測期內，人工智慧驅動的監測平台細分市場預計將呈現最高的成長率，這反映出對智慧數據分析層的大力投資，這些分析層能夠將原始的遠端患者監測（RPM）數據轉化為預測性的臨床洞察。醫療服務提供者和保險公司優先考慮那些能夠將多設備資料聚合與基於機器學習的早期預警功能相結合的平台，這些平台使醫護團隊能夠在不利事件發生之前主動干預。基於患者時間序列資料集訓練的臨床級人工智慧演算法的日益普及，正在加速平台的成熟和在各種醫療環境中的商業部署。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於有利的報銷政策、慢性病高發生率以及先進的數位健康生態系統。美國在區域內引領遠距病患監護（RPM）技術的普及，這得益於其擴展性法規，這些法規將RPM報銷永久納入了聯邦醫療保險（Medicare）和私人保險體系。完善的居家醫療基礎設施以及對連線健診硬體和分析平台的強勁風險投資，持續鞏固北美在市場上的主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於醫療保險覆蓋範圍的擴大、日本、中國和韓國老年人口的快速成長，以及智慧型手機普及率的提高，從而推動了行動連線監測解決方案的發展。印度和東南亞政府主導的數位健康舉措正在加速遠距患者監測（RPM）在基層醫療和農村醫療機構的應用。價格合理的物聯網硬體製造與不斷擴展的遠端醫療基礎設施的融合，使亞太地區成為全球遠端患者監護設備成長最強勁的地區。

免費客製化服務：

所有購買此報告的客戶均可選擇以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球遠端患者監護設備市場：依產品類型分類

  • 生命徵象監測
    • 血壓監測儀
    • 脈搏血氧飽和度分析儀
    • 心率監測器（ECG）
    • 體溫監測器
    • 呼吸頻率監測器
    • 腦電圖監測設備（EEG）
  • 專用顯示器
    • 血糖值監測儀
    • 心率節律監測
    • 多參數監測設備
    • 胎兒及新生兒監視器
    • 睡眠監測設備
    • 呼吸監測設備
    • 體重監測設備
    • 活動及健身監測設備

第6章：全球遠端患者監護設備市場：按設備類型分類

  • 穿戴式裝置
  • 手持裝置
  • 嵌入式監控設備
  • 行動連線設備

第7章 全球遠端患者監護設備市場：依技術分類

  • 無線監控設備
  • 支援藍牙的設備
  • 蜂窩網路連接設備
  • 基於雲端的監控系統
  • 人工智慧監控平台
  • 基於物聯網的監控解決方案

第8章：全球遠端患者監護設備市場：按分銷管道分類

  • 直銷
  • 零售藥房
  • 線上管道
  • 醫療設備銷售代理

第9章 全球遠端患者監護設備市場：按應用領域分類

  • 心血管疾病
  • 糖尿病管理
  • 高血壓監測
  • 呼吸系統疾病
  • 神經病變
  • 睡眠障礙
  • 癌症治療監測
  • 術後監測
  • 老年護理監測

第10章 全球遠端患者監護設備市場：依最終用戶分類

  • 醫院
  • 居家醫療設施
  • 門診部
  • 診所和私人診所
  • 長期照護機構
  • 復健中心
  • 研究和學術機構

第11章 全球遠端患者監護設備市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Medtronic plc
  • Abbott Laboratories
  • Koninklijke Philips NV
  • GE HealthCare
  • Boston Scientific Corporation
  • Dexcom, Inc.
  • Masimo Corporation
  • Omron Corporation
  • Nihon Kohden Corporation
  • Biotronik SE & Co. KG
  • ResMed Inc.
  • AliveCor, Inc.
  • Teladoc Health, Inc.
  • VitalConnect, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Product Code: SMRC36751

According to Stratistics MRC, the Global Remote Patient Monitoring Devices Market is accounted for $6.1 billion in 2026 and is expected to reach $19.4 billion by 2034, growing at a CAGR of 15.6% during the forecast period. Remote Patient Monitoring (RPM) Devices encompass a broad category of medical-grade hardware and connected digital tools designed to collect, transmit, and analyze patient physiological data outside conventional clinical settings. These devices span vital sign monitors, wearable biosensors, implantable cardiac devices, and multi-parameter platforms, enabling continuous health surveillance for individuals managing chronic diseases or recovering post-operatively. By bridging the gap between patients and care teams in real time, RPM devices reduce hospital readmissions, support proactive clinical intervention, lower healthcare costs, and empower patients to actively participate in their own health management.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases and aging global population

The accelerating global burden of chronic conditions including cardiovascular disease, diabetes, hypertension, and respiratory disorders is generating sustained demand for continuous monitoring technologies that enable proactive care management between clinical visits. An aging global population further amplifies this need, as elderly individuals require frequent health assessments that traditional in-person models cannot efficiently accommodate. RPM devices provide clinicians with longitudinal health data streams that enable timely interventions, reducing disease progression and costly emergency hospitalizations. Expanding reimbursement coverage for remote monitoring programs across major markets is reinforcing adoption momentum among both providers and patients.

Restraint:

Data privacy regulations and connectivity limitations in rural areas

The collection and transmission of sensitive patient health data by RPM devices places significant compliance obligations on healthcare providers and device manufacturers under frameworks such as HIPAA, GDPR, and emerging national digital health regulations. Ensuring end-to-end data encryption, patient consent management, and audit trail integrity adds operational complexity and cost. Additionally, unreliable broadband and cellular connectivity in rural and remote regions undermines the real-time data transmission that RPM effectiveness depends upon. These infrastructure deficits create geographic inequities in RPM access, limiting market penetration precisely in communities with the greatest potential clinical benefit.

Opportunity:

Integration of AI analytics and expansion of home healthcare models

The convergence of RPM hardware with AI-powered analytics platforms is transforming raw physiological data into actionable clinical intelligence, enabling predictive deterioration alerts and personalized care pathway recommendations. This value-added capability is attracting significant investment from health systems, insurers, and technology companies seeking to differentiate their remote care offerings. Concurrently, the structural shift toward home-based healthcare delivery driven by cost pressures, patient preference, and post-pandemic care model transformation is expanding the serviceable market for RPM devices across chronic disease management, post-surgical monitoring, and eldercare segments.

Threat:

Device accuracy concerns and reimbursement policy uncertainty

Consumer-grade wearable devices entering the clinical monitoring space raise significant accuracy and regulatory compliance concerns, as many lack rigorous validation for medical-grade applications. Clinicians remain cautious about relying on data from devices with inconsistent performance across diverse patient populations, including those with darker skin tones or higher BMIs. Furthermore, reimbursement policies for RPM services remain inconsistent across payers and geographies, creating uncertainty for healthcare providers investing in monitoring infrastructure. Revisions to telehealth billing codes or tightening of coverage criteria could materially impact adoption rates and return-on-investment timelines for RPM programs.

Covid-19 Impact:

The COVID-19 pandemic dramatically accelerated RPM adoption as healthcare systems urgently transitioned non-critical patient monitoring outside hospital walls to preserve inpatient capacity for severe COVID-19 cases. Emergency regulatory flexibilities enabled rapid RPM deployment and broadened telehealth reimbursement, establishing new care delivery norms that persisted beyond the acute crisis. The pandemic illustrated RPM's capacity to maintain care continuity during system disruptions, prompting health systems and policymakers to formalize RPM within standard care pathways and invest in scalable digital health infrastructure for future resilience.

The Vital Sign Monitors segment is expected to be the largest during the forecast period

The vital sign monitors segment is expected to account for the largest market share during the forecast period, encompassing high-demand devices including blood pressure monitors, pulse oximeters, and ECG heart rate monitors. These foundational monitoring tools address the broadest chronic disease management needs, commanding widespread deployment across hospital-at-home programs, post-discharge care, and long-term condition management. Continued product innovation delivering clinical-grade accuracy in compact, user-friendly form factors sustains this segment's dominant revenue contribution throughout the forecast horizon.

The AI-Enabled Monitoring Platforms segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the AI-Enabled Monitoring Platforms segment is predicted to witness the highest growth rate, reflecting robust investment in intelligent data analytics layers that transform raw RPM data into predictive clinical insights. Health systems and payors are prioritizing platforms that combine multi-device data aggregation with machine learning-driven early warning capabilities, enabling proactive care team intervention before adverse events occur. The expanding availability of clinical-grade AI algorithms trained on longitudinal patient datasets is accelerating platform maturity and commercial deployment across diverse care settings.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by favorable reimbursement policies, high chronic disease prevalence, and an advanced digital health ecosystem. The United States leads regional adoption following regulatory expansions that permanently incorporated RPM reimbursement within Medicare and commercial payer frameworks. A well-established home healthcare infrastructure and strong venture investment in connected health hardware and analytics platforms continue to reinforce North America's leading market position.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by expanding healthcare coverage programs, rapidly growing elderly populations in Japan, China, and South Korea, and rising smartphone penetration enabling mobile-connected monitoring solutions. Government digital health initiatives in India and Southeast Asia are facilitating RPM deployment in primary care and rural health settings. The convergence of affordable IoT hardware manufacturing and expanding telehealth infrastructure makes Asia Pacific the most dynamic growth frontier for remote patient monitoring devices globally.

Key players in the market

Some of the key players in Remote Patient Monitoring Devices Market include Medtronic plc, Abbott Laboratories, Koninklijke Philips N.V., GE HealthCare, Boston Scientific Corporation, Dexcom, Inc., Masimo Corporation, Omron Corporation, Nihon Kohden Corporation, Biotronik SE & Co. KG, ResMed Inc., AliveCor, Inc., Teladoc Health, Inc., VitalConnect, Inc., and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Key Developments:

In February 2026, Dexcom announced the commercial launch of its next-generation continuous glucose monitoring platform featuring enhanced real-time data sharing capabilities and AI-driven glycemic trend prediction, expanding its addressable market to include type 2 diabetes patients not requiring insulin therapy.

In January 2026, Masimo Corporation entered into a multi-year strategic partnership with a global health insurer to integrate its wearable remote monitoring platform into a value-based care program targeting high-risk cardiovascular patients, enabling continuous vital sign surveillance and automated clinical escalation protocols.

Product Types Covered:

  • Vital Sign Monitors
  • Specialized Monitors

Device Forms Covered:

  • Wearable Devices
  • Handheld Devices
  • Implantable Monitoring Devices
  • Mobile-Connected Devices

Technologies Covered:

  • Wireless Monitoring Devices
  • Bluetooth-Enabled Devices
  • Cellular-Connected Devices
  • Cloud-Based Monitoring Systems
  • AI-Enabled Monitoring Platforms
  • IoT-Based Monitoring Solutions

Distribution Channels Covered:

  • Direct Sales
  • Retail Pharmacies
  • Online Channels
  • Medical Device Distributors

Applications Covered:

  • Cardiovascular Diseases
  • Diabetes Management
  • Hypertension Monitoring
  • Respiratory Disorders
  • Neurological Disorders
  • Sleep Disorders
  • Cancer Care Monitoring
  • Postoperative Monitoring
  • Elderly Care Monitoring

End Users Covered:

  • Hospitals
  • Home Healthcare Settings
  • Ambulatory Care Centers
  • Clinics & Physician Offices
  • Long-Term Care Centers
  • Rehabilitation Centers
  • Research & Academic Institutes

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Remote Patient Monitoring Devices Market, By Product Type

  • 5.1 Vital Sign Monitors
    • 5.1.1 Blood Pressure Monitors
    • 5.1.2 Pulse Oximeters
    • 5.1.3 Heart Rate Monitors (ECG)
    • 5.1.4 Temperature Monitors
    • 5.1.5 Respiratory Rate Monitors
    • 5.1.6 Brain Monitoring Devices (EEG)
  • 5.2 Specialized Monitors
    • 5.2.1 Blood Glucose Monitors
    • 5.2.2 Cardiac Rhythm Monitors
    • 5.2.3 Multi-Parameter Monitoring Devices
    • 5.2.4 Fetal & Neonatal Monitors
    • 5.2.5 Sleep Monitoring Devices
    • 5.2.6 Respiratory Monitoring Devices
    • 5.2.7 Weight Monitoring Devices
    • 5.2.8 Activity & Fitness Monitoring Devices

6 Global Remote Patient Monitoring Devices Market, By Device Form

  • 6.1 Wearable Devices
  • 6.2 Handheld Devices
  • 6.3 Implantable Monitoring Devices
  • 6.4 Mobile-Connected Devices

7 Global Remote Patient Monitoring Devices Market, By Technology

  • 7.1 Wireless Monitoring Devices
  • 7.2 Bluetooth-Enabled Devices
  • 7.3 Cellular-Connected Devices
  • 7.4 Cloud-Based Monitoring Systems
  • 7.5 AI-Enabled Monitoring Platforms
  • 7.6 IoT-Based Monitoring Solutions

8 Global Remote Patient Monitoring Devices Market, By Distribution Channel

  • 8.1 Direct Sales
  • 8.2 Retail Pharmacies
  • 8.3 Online Channels
  • 8.4 Medical Device Distributors

9 Global Remote Patient Monitoring Devices Market, By Application

  • 9.1 Cardiovascular Diseases
  • 9.2 Diabetes Management
  • 9.3 Hypertension Monitoring
  • 9.4 Respiratory Disorders
  • 9.5 Neurological Disorders
  • 9.6 Sleep Disorders
  • 9.7 Cancer Care Monitoring
  • 9.8 Postoperative Monitoring
  • 9.9 Elderly Care Monitoring

10 Global Remote Patient Monitoring Devices Market, By End User

  • 10.1 Hospitals
  • 10.2 Home Healthcare Settings
  • 10.3 Ambulatory Care Centers
  • 10.4 Clinics & Physician Offices
  • 10.5 Long-Term Care Centers
  • 10.6 Rehabilitation Centers
  • 10.7 Research & Academic Institutes

11 Global Remote Patient Monitoring Devices Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Medtronic plc
  • 14.2 Abbott Laboratories
  • 14.3 Koninklijke Philips N.V.
  • 14.4 GE HealthCare
  • 14.5 Boston Scientific Corporation
  • 14.6 Dexcom, Inc.
  • 14.7 Masimo Corporation
  • 14.8 Omron Corporation
  • 14.9 Nihon Kohden Corporation
  • 14.10 Biotronik SE & Co. KG
  • 14.11 ResMed Inc.
  • 14.12 AliveCor, Inc.
  • 14.13 Teladoc Health, Inc.
  • 14.14 VitalConnect, Inc.
  • 14.15 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

List of Tables

  • Table 1 Global Remote Patient Monitoring Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Remote Patient Monitoring Devices Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Remote Patient Monitoring Devices Market Outlook, By Vital Sign Monitors (2023-2034) ($MN)
  • Table 4 Global Remote Patient Monitoring Devices Market Outlook, By Blood Pressure Monitors (2023-2034) ($MN)
  • Table 5 Global Remote Patient Monitoring Devices Market Outlook, By Pulse Oximeters (2023-2034) ($MN)
  • Table 6 Global Remote Patient Monitoring Devices Market Outlook, By Heart Rate Monitors (ECG) (2023-2034) ($MN)
  • Table 7 Global Remote Patient Monitoring Devices Market Outlook, By Temperature Monitors (2023-2034) ($MN)
  • Table 8 Global Remote Patient Monitoring Devices Market Outlook, By Respiratory Rate Monitors (2023-2034) ($MN)
  • Table 9 Global Remote Patient Monitoring Devices Market Outlook, By Brain Monitoring Devices (EEG) (2023-2034) ($MN)
  • Table 10 Global Remote Patient Monitoring Devices Market Outlook, By Specialized Monitors (2023-2034) ($MN)
  • Table 11 Global Remote Patient Monitoring Devices Market Outlook, By Blood Glucose Monitors (2023-2034) ($MN)
  • Table 12 Global Remote Patient Monitoring Devices Market Outlook, By Cardiac Rhythm Monitors (2023-2034) ($MN)
  • Table 13 Global Remote Patient Monitoring Devices Market Outlook, By Multi-Parameter Monitoring Devices (2023-2034) ($MN)
  • Table 14 Global Remote Patient Monitoring Devices Market Outlook, By Fetal & Neonatal Monitors (2023-2034) ($MN)
  • Table 15 Global Remote Patient Monitoring Devices Market Outlook, By Sleep Monitoring Devices (2023-2034) ($MN)
  • Table 16 Global Remote Patient Monitoring Devices Market Outlook, By Respiratory Monitoring Devices (2023-2034) ($MN)
  • Table 17 Global Remote Patient Monitoring Devices Market Outlook, By Weight Monitoring Devices (2023-2034) ($MN)
  • Table 18 Global Remote Patient Monitoring Devices Market Outlook, By Activity & Fitness Monitoring Devices (2023-2034) ($MN)
  • Table 19 Global Remote Patient Monitoring Devices Market Outlook, By Device Form (2023-2034) ($MN)
  • Table 20 Global Remote Patient Monitoring Devices Market Outlook, By Wearable Devices (2023-2034) ($MN)
  • Table 21 Global Remote Patient Monitoring Devices Market Outlook, By Handheld Devices (2023-2034) ($MN)
  • Table 22 Global Remote Patient Monitoring Devices Market Outlook, By Implantable Monitoring Devices (2023-2034) ($MN)
  • Table 23 Global Remote Patient Monitoring Devices Market Outlook, By Mobile-Connected Devices (2023-2034) ($MN)
  • Table 24 Global Remote Patient Monitoring Devices Market Outlook, By Technology (2023-2034) ($MN)
  • Table 25 Global Remote Patient Monitoring Devices Market Outlook, By Wireless Monitoring Devices (2023-2034) ($MN)
  • Table 26 Global Remote Patient Monitoring Devices Market Outlook, By Bluetooth-Enabled Devices (2023-2034) ($MN)
  • Table 27 Global Remote Patient Monitoring Devices Market Outlook, By Cellular-Connected Devices (2023-2034) ($MN)
  • Table 28 Global Remote Patient Monitoring Devices Market Outlook, By Cloud-Based Monitoring Systems (2023-2034) ($MN)
  • Table 29 Global Remote Patient Monitoring Devices Market Outlook, By AI-Enabled Monitoring Platforms (2023-2034) ($MN)
  • Table 30 Global Remote Patient Monitoring Devices Market Outlook, By IoT-Based Monitoring Solutions (2023-2034) ($MN)
  • Table 31 Global Remote Patient Monitoring Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 32 Global Remote Patient Monitoring Devices Market Outlook, By Direct Sales (2023-2034) ($MN)
  • Table 33 Global Remote Patient Monitoring Devices Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 34 Global Remote Patient Monitoring Devices Market Outlook, By Online Channels (2023-2034) ($MN)
  • Table 35 Global Remote Patient Monitoring Devices Market Outlook, By Medical Device Distributors (2023-2034) ($MN)
  • Table 36 Global Remote Patient Monitoring Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 37 Global Remote Patient Monitoring Devices Market Outlook, By Cardiovascular Diseases (2023-2034) ($MN)
  • Table 38 Global Remote Patient Monitoring Devices Market Outlook, By Diabetes Management (2023-2034) ($MN)
  • Table 39 Global Remote Patient Monitoring Devices Market Outlook, By Hypertension Monitoring (2023-2034) ($MN)
  • Table 40 Global Remote Patient Monitoring Devices Market Outlook, By Respiratory Disorders (2023-2034) ($MN)
  • Table 41 Global Remote Patient Monitoring Devices Market Outlook, By Neurological Disorders (2023-2034) ($MN)
  • Table 42 Global Remote Patient Monitoring Devices Market Outlook, By Sleep Disorders (2023-2034) ($MN)
  • Table 43 Global Remote Patient Monitoring Devices Market Outlook, By Cancer Care Monitoring (2023-2034) ($MN)
  • Table 44 Global Remote Patient Monitoring Devices Market Outlook, By Postoperative Monitoring (2023-2034) ($MN)
  • Table 45 Global Remote Patient Monitoring Devices Market Outlook, By Elderly Care Monitoring (2023-2034) ($MN)
  • Table 46 Global Remote Patient Monitoring Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 47 Global Remote Patient Monitoring Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 48 Global Remote Patient Monitoring Devices Market Outlook, By Home Healthcare Settings (2023-2034) ($MN)
  • Table 49 Global Remote Patient Monitoring Devices Market Outlook, By Ambulatory Care Centers (2023-2034) ($MN)
  • Table 50 Global Remote Patient Monitoring Devices Market Outlook, By Clinics & Physician Offices (2023-2034) ($MN)
  • Table 51 Global Remote Patient Monitoring Devices Market Outlook, By Long-Term Care Centers (2023-2034) ($MN)
  • Table 52 Global Remote Patient Monitoring Devices Market Outlook, By Rehabilitation Centers (2023-2034) ($MN)
  • Table 53 Global Remote Patient Monitoring Devices Market Outlook, By Research & Academic Institutes (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.